Annotation
Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
| The first 150 words of the full text of this article appear below. |
 |
Introduction |
|---|
Almost simultaneously with a request to prescribe any novel
treatment for our patients, the bellowing voices of the Mr Bumbles, to
be found inhabiting our drug and therapeutic committees and our local
family health services authorities, will be heard to exclaim, `More!
after he has prescribed the drugs already allotted by the
pharmacy!'1 Thus those of us committed to the care of patients with cystic fibrosis should not have been surprised to encounter a wall of resistance to the introduction of recombinant human
DNase (rhDNase) at an estimated cost of £7500 per patient per year.
Even after multicentre, international studies conducted by most
respected colleagues we were asked to make the case again, and to prove
its efficacy and cost effectiveness.
| Table Removed (Available Only in the Full Text) |
| |
What is cost effectiveness in cystic fibrosis? |
|---|
The concept of cost effectiveness is fraught with difficulties for
clinicians committed to the care of patients with cystic fibrosis.
There is no easily defined starting point and no
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Doull, I. J M
(2001). Recent advances: Recent advances in cystic fibrosis. Arch. Dis. Child.
85: 62-66
[Abstract] [Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in ADC Online
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
